Characteristics of COPD in never-smokers and ever-smokers in the general population: Results from the CanCOLD study

Thorax

Volumn 70, Issue 9, 2015, Pages 822-829

  Tan, W C ^a   Sin, D D ^a   Bourbeau, Jean ^b,p   Hernandez, P ^c,l   Chapman, K R ^d   Cowie, R ^e   FitzGerald, J M ^a   Marciniuk, D D ^f   Maltais, F ^g,m   Buist, A S ^h   Road, Jeremy ^a   Hogg, J C ^a   Kirby, Miranda ^a   Coxson, Harvey ^a   Hague, Cameron ^a,i   Leipsic, Jonathon ^a,i   O'Donnell, D E ^j   Aaron, S D ^k   Samet, Jonathon ⁿ   Puhan, Milo ^o   Hamid, Qutayba ^b   Baglole, Carole ^p   Jabet, Carole ^p   Tam, Sheena ^a   Comeau, Joe ^a   Png, Adrian ^a   Sadatsafavi, Mohsen ^a   To, Teresa ^d   Gershon, Andrea ^d   Li, Pei Zhi ^b   Duquette, Jean Francois ^b   Fortier, Yvan ^b,p   Benedetti, Andrea ^b   Jensen, Denis ^b   Lo, Christine ^a   Cheng, Sarah ^a   Fung, Cindy ^a   Ferguson, Nancy ^a   Haynes, Nancy ^a   Chuang, Junior ^a   Li, Licong ^a   Bayat, Selva ^a   Wong, Amanda ^a   Alavi, Zoe ^a   Peng, Catherine ^a   Zhao, Bin ^a   Scott Hsiung, Nathalie ^a   Nadirshaw, Tasha ^a   Mancino, Palmina ^b,p   Latreille, David ^b   Baril, Jacinthe ^b   Labonte, Laura ^b   McClean, Patricia ^d   Audisho, Nadeen ^d   Cowie, Ann ^e   Dumonceaux, Curtis ^e   Machado, Lisette ^e   Vandemheen, Kathy ^k   Pratt, Gay ^k   Bergeron, Amanda ^k   Brouillard, Cynthia ^m   Clemens, Ron ^f   Baran, Janet ^f   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ ST PAUL S HOSPITAL   (Canada)

^j QUEEN S UNIVERSITY   (Canada)

^k OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^l DALHOUSIE UNIVERSITY   (Canada)

^m UNIVERSITÉ LAVAL   (Canada)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^p MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FUEL; PASSIVE SMOKING;

ADULT; AGE; AGED; ARTICLE; ASTHMA; CHILD HOSPITALIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESIDUAL VOLUME; SELF REPORT; SEX DIFFERENCE; SMOKING; TOTAL LUNG CAPACITY; ADVERSE EFFECTS; AIRWAY OBSTRUCTION; CANADA; CLINICAL TRIAL; HOSPITALIZATION; LUNG; MIDDLE AGED; MULTICENTER STUDY; PASSIVE SMOKING; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; AIRWAY OBSTRUCTION; CANADA; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84941268920     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-206938     Document Type: Article

References (35)

1. Smith M, Li L, Augustyn M, et al. Prevalence and correlates of airflow obstruction in approximately 317,000 never-smokers in China. Eur Respir J 2014;44:66-77.
2. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733-43.
3. Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006;61:1043-7.
4. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003;97:115-22.
5. Celli BR, Halbert RJ, Nordyke RJ, et al. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 2005;118:1364-72.
6. Zhou Y, Wang C, Yao W, et al. COPD in Chinese nonsmokers. Eur Respir J 2009;33:509-18.
7. Bridevaux PO, Probst-Hensch NM, Schindler C, et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J 2010;36:1259-69.
8. Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011;139:752-63.
9. Perez-Padilla R, Fernandez R, Lopez Varela MV, et al. Airflow obstruction in never smokers in five Latin American cities: the PLATINO study. Arch Med Res 2012;43:159-65.
10. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;182:693-718.
11. Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res 2013;162:208-18.
12. Perez-Padilla R, Schilmann A, Riojas-Rodriguez H. Respiratory health effects of indoor air pollution. Int J Tuberc Lung Dis 2010;14:1079-86.
13. Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 2005;128:1239-44.
14. Chilvers ER, Lomas DA. Diagnosing COPD in non-smokers: splitting not lumping. Thorax 2010;65:465-6.
15. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50.
16. Tan WC, Bourbeau J, FitzGerald JM, et al. Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada. Int J Tuberc Lung Dis 2011;15:1691-8.
17. GOLD. Global strategy for Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2015. http://www.goldcopd. org/(accessed 2 Feb 2015).
18. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-87.
19. Bourbeau J, Tan WC, Benedetti A, et al. Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD 2012;11:125-32.
20. Barr RG, Berkowitz EA, Bigazzi F, et al. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD 2012;9:151-9.
21. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
22. Birring SS, Brightling CE, Bradding P, et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med 2002;166:1078-83.
23. Ramirez-Venegas A, Sansores RH, Quintana-Carrillo RH, et al. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. Am J Respir Crit Care Med 2014;190:996-1002.
24. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-200.
25. Rehfuess E, Mehta S, Pruss-Ustun A. Assessing household solid fuel use: multiple implications for the Millennium Development Goals. Environ Health Perspect 2006;114:373-8.
26. Sorheim IC, Johannessen A, Gulsvik A, et al. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax 2010;65:480-5.
27. Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006;61:105-10.
28. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010;65:14-20.
29. Thomsen M, Nordestgaard BG, Vestbo J, et al. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Lancet Respir Med 2013;1:543-50.
30. Wedzicha JA, Brill SE, Allinson JP, et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med 2013;11:181.
31. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182:598-604.
32. Tan WC, Bourbeau J, Hernandez P, et al. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Thorax 2014;69:709-17.
33. Vestbo J. COPD: definition and phenotypes. Clin Chest Med 2014;35:1-6.
34. Mannino DM, Sonia Buist A, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007;62:237-41.
35. Guder G, Brenner S, Angermann CE, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res 2012;13:13.